Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, ...

Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, hopes to use the conference to explore how ...

Point-of-care engagement is essential for converting investments in payer negotiations and copay programs into prescriptions.

That era is ending. Policy reform, economic pressure, and patient empowerment have fractured that reality into three distinct ...

Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses how the convergence of patient access ...

Counterfeit pharma networks are becoming more sophisticated—leveraging advanced packaging, fragmented logistics, and global ...

In today’s Pharma Pulse, Augmentin XR is the first drug approved under the FDA's new CNPV pilot program and much more.

In addition, many adults (67%) also think policymakers should keep access- and coverage-related factors in mind, namely ...

In today’s Pharma Pulse, the University of Maryland expands its medical class to combat physician shortages and much more.

The 20th installment of Trade & Channel Strategies carried on with a focus on boosting access to medication.

This shift in data analysis enables what can be called a “precision medical affairs” approach. Instead of a one-size-fits-all ...

The Health Data, Technology, and Interoperability (HTI-4) Final Rule aims to strengthen the nation’s health IT ecosystem by ...